Cordyceps Sunshine Biotech Holdings Co., Ltd. Operating Expenses
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) reported Operating Expenses of $901.87 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-05-15
- Cordyceps Sunshine Biotech Holdings Co., Ltd. operating expenses for the quarter ending 2023-12-31 was $164.21K, a 114.77% increase year-over-year.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. operating expenses for the quarter ending 2022-12-31 was $76.46K.
| Period end | Operating Expenses 3 month | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $901.87K 20-F · filed 2026-05-15 | ||||
| 2024-12-31 | $1.09M 20-F · filed 2026-05-15 | $717.67K 20-F · filed 2025-06-13 | |||
| 2023-12-31 | $164.21K derived: 20-F 12 month − 6-K 9 month · filed 2026-05-15 | $538.55K 20-F · filed 2026-05-15 | $541.00K 20-F · filed 2024-07-05 | ||
| 2023-09-30 | $374.34K 6-K · filed 2023-11-13 | ||||
| 2022-12-31 | $76.46K derived: 20-F/A 12 month − 6-K 9 month · filed 2025-09-23 | $454.68K 20-F/A · filed 2025-09-23 | $576.03K 20-F · filed 2023-05-15 | ||
| 2022-09-30 | $378.22K 6-K · filed 2023-11-13 | ||||
| 2021-12-31 | $119.39K 20-F/A · filed 2025-09-23 | $300.97K 20-F · filed 2023-05-15 | |||
| 2020-12-31 | $85.34K 20-F · filed 2023-05-15 |